Impact of coronavirus pandemic on cancer patients; is it time for ectoine and/or ACE inhibitors?
<p>Cancer patients require attention after COVID-19. ACEI and/or ectoine could represent potential adjuvant therapy. Clinical trials are required to investigate this hope to mitigate COVID-19 infectivity and cell invasion.</p>
Na minha lista:
Autor principal: | Eman El-Abd (Author) |
---|---|
Formato: | Livro |
Publicado em: |
Journal of Gynecological Research and Obstetrics - Peertechz Publications,
2020-04-24.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registos relacionados
-
Pre-irradiation effects of ectoine on radiation-induced cardiotoxicity in female Swiss albino mice model
Por: Sameh Nakhla, et al.
Publicado em: (2022) -
Ectoine, from a Natural Bacteria Protectant to a New Treatment of Dry Eye Disease
Por: Xin Chen, et al.
Publicado em: (2024) -
Effects of Ectoine on Behavior and Candidate Genes Expression in ICV-STZ Rat Model of Sporadic Alzheimer's Disease
Por: Niloofar Bazazzadegan, et al.
Publicado em: (2017) -
ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients
Por: David S. Weisman, et al.
Publicado em: (2020) -
Use of ACE-inhibitors in Serbia in 2009 and 2010
Por: Perić Dajana M., et al.
Publicado em: (2014)